<DOC>
	<DOCNO>NCT01816412</DOCNO>
	<brief_summary>To demonstrate safety efficacy MD02-LDCB treatment stenosis occlusion femoral popliteal artery Japanese population .</brief_summary>
	<brief_title>LEVANT Japan Clinical Trial</brief_title>
	<detailed_description>The study enroll patient present claudication ischemic rest pain angiographically significant lesion superficial femoral popliteal artery patent outflow artery foot . After successful protocol-defined pre-dilatation , subject determine require stenting base define angiographic criterion randomize 2:1 treatment either MD02-LDCB ( test arm ) standard PTA catheter ( control arm ) use similar technique . Subjects meet post-predilatation lesion criterion exclude ( treat per standard practice ) follow safety 30 day . Randomized subject ultrasound follow-up 2 year consent 2 year clinical follow-up .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>Male nonpregnant female ≥20 year age ; Rutherford Clinical Category 24 ; Length ≤15 cm ; ≥70 % stenosis Lesion location start ≥1 cm common femoral bifurcation terminates distally ≤2 cm tibial plateau AND ≥1 cm origin TP trunk ; A patent inflow artery confirm angiography At least one patent native outflow artery ankle Life expectancy &lt; 2 year ; History hemorrhagic stroke within 3 month ; Previous plan surgical interventional procedure within 2 week within 30 day index procedure ; History MI , thrombolysis angina within 2 week enrollment ; Renal failure chronic kidney disease Severe calcification render lesion undilatable</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Arms</keyword>
	<keyword>Experimental</keyword>
	<keyword>Drug Coated Angioplasty Balloon</keyword>
	<keyword>Active Comparator</keyword>
	<keyword>Standard angioplasty balloon</keyword>
</DOC>